Artificial intelligence is transforming how we live and work, from personalized recommendations to health care innovation.
As we approach 2025, the landscape of business operations is rapidly evolving, driven by new artificial intelligence (AI) automation trends. These innovations are not just incremental improvements; ...
On the cusp of a new year, enterprise IT faces a fascinating conundrum: One of the least automated functions in any company is IT itself. I expect that to change, though it won’t always make for a ...
NEW YORK--(BUSINESS WIRE)--UiPath (NYSE: PATH), a global leader in agentic automation, today announced it has been positioned by Gartner, Inc. as a Leader in the 2025 Gartner® Magic Quadrant™ for ...
With artificial intelligence (AI) advancing rapidly, there needs to be more clarity about what generative AI means for process automation. After all, process automation has been around for decades, ...
Effective pre-implementation planning is critical for successful adoption of intelligent process automation (IPA). The comprehensive IPA pre-implementation framework outlined in this document provides ...
If you separately ask 10 industrial automation experts what the hottest trends of the moment are, you’ll likely get 10 different answers depending on the technologies they work with and in which ...
Aerospace and Mechanical Insider on MSN
Assembly automation market driven by IoT and 5G
The global assembly automation market, valued at USD 56.17 billion in 2024, is projected to reach USD 121.16 billion by 2033, registering a compound annual growth rate of 8.9% from 2025 to 2033.
CHICAGO--(BUSINESS WIRE)--ONDEX Automation today announced the acquisition of The Fitch Company, a leading electrical engineering and process automation systems integrator based in Rumford, Maine.
The International Society of Automation (ISA) — the leading professional society for automation — announced that its ISASecure ® program has been selected by The Open Group Open Process Automation™ ...
Successfully producing large quantities of biotherapeutics, including monoclonal antibodies and recombinant protein products, depends on robust and reliable cell line development (CLD). Issues that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results